01—Abstract
Summary
Summary of the 6-K filed December 20, 2024. Cited figures are marked; the original filing is the authoritative source.
This Form 6-K furnishes James Hardie Industries plc's ASX announcements from mid-December 2024, consisting mainly of equity administration notices rather than financial results.
The filing contains no income statement, earnings, or guidance figures. The company reports the issue of 322,380 CHESS Depositary Interests (CDIs) on 9 December 2024 under an employee incentive scheme for nil cash consideration, bringing total quoted CDIs to 429,782,148 per the Appendix 2A. It also reports the grant of 560,410 restricted stock units (RSUs) on 9 December 2024, comprising 462,689 RSUs under the 2001 Plan, 13,762 Relative Total Shareholder Return RSUs and 83,959 European EBIT RSUs.
After the issue, the Appendix 3G lists 3,839,125 RSUs and 269,221 options (expiring 03-Nov-2027, exercise price $33.05a) as unquoted securities on issue. The filing also covers 4,951 CDIs issued on 13 December 2024 under the James Hardie 2020 Non-Executive Director Equity Plan, quoted on 17 December 2024. Nine Appendix 3Y notices, all dated 13 December 2024, report the same non-executive director plan issuance of American Depositary Receipts (ADRs) to directors, including Peter John Charles Davis, Persio Lisboa, Anne Lloyd, Renee Peterson, John C Pfeifer, Rada Rodriguez, Suzanne Rowland, Nigel Stein and Harold Wiens.
The largest single receipt reported is 1,093 ADRs by Renee Peterson, valued at US$39,096.61b. The Appendix 3G also records a grant of 10,231 RSUs to key management person Christian Claus.
The filing includes standard forward-looking statement cautions, which reference the Form 20-F filed with the SEC on 20 May 2024 for risk factors. For investors, the document is primarily useful as a record of routine share-based compensation issuance and director share acquisitions, with no new financial or operational disclosures.
02—Key points
Key Highlights
- 322,380 CDIs issued on 9 December 2024 under an employee incentive scheme for nil cash consideration, with total quoted CDIs of 429,782,148 following quotation.
- 560,410 RSUs granted on 9 December 2024: 462,689 under the 2001 Plan, 13,762 Relative TSR RSUs and 83,959 European EBIT RSUs.
- After the RSU grant, 3,839,125 RSUs and 269,221 options (expiring 03-Nov-2027, exercise price $33.05) are reported as unquoted securities on issue.
- 4,951 CDIs issued on 13 December 2024 under the 2020 Non-Executive Director Equity Plan and quoted on 17 December 2024.
- Nine directors each reported acquisitions of ADRs on 13 December 2024 under the 2020 Non-Executive Director Equity Plan, ranging from 381 to 1,093 ADRs per director.
- Christian Claus, a key management person, was granted 10,231 RSUs, and Timothy Beastrom, Christian Claus and Farhaj Majeed were listed with CDI issuances of 3,170, 2,022 and 3,805 respectively.
03—Questions
Frequently Asked Questions
Does this filing include financial results or guidance?
No. The filing consists of ASX appendices and director change-of-interest notices covering equity issuances and director share acquisitions. It does not contain financial results, earnings figures or guidance.
How many securities were issued under employee incentive arrangements?
The filing reports 322,380 CDIs issued on 9 December 2024 under an employee incentive scheme, and 560,410 RSUs granted on the same date. It also reports 4,951 CDIs issued on 13 December 2024 under the 2020 Non-Executive Director Equity Plan.
What was the consideration for these issuances?
The filing states that the CDIs issued under the employee incentive scheme were issued for nil cash consideration, with an estimated value of A$0.000000 per security. The non-executive director CDIs were also reported at 0.000000 per security.
Did directors buy shares in December 2024?
The Appendix 3Y notices report that each of nine directors received ADRs on 13 December 2024 under the 2020 Non-Executive Director Equity Plan. The filing states the number of ADRs acquired and the related values, such as US$39,096.61 for Renee Peterson's 1,093 ADRs, and does not indicate any disposals.
What is the filing's reference to risk factors?
The filing's cautionary statement refers readers to the Risk Factors section in Section 3 of the Form 20-F filed with the SEC on 20 May 2024, and to other risks identified in the company's reports filed with Australian, Irish and US regulators.
04—Continue